H. Lundbeck A/s
Clinical trials sponsored by H. Lundbeck A/s, explained in plain language.
-
New Parkinson's drug candidate enters first safety tests in china
Disease control Not yet recruitingThis early-stage trial will test the safety and tolerability of a new oral drug called Lu AF28996 in 10 Chinese adults with Parkinson's disease. Participants will take the drug and be monitored for side effects and how the body processes it. The study is not yet recruiting and do…
Phase: PHASE1 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New Parkinson's pill aims to cut 'OFF' time and ease daily struggles
Symptom relief Not yet recruitingThis Phase 2 trial tests whether adding Lu AF28996 to standard Parkinson's medications can extend the time patients feel their movement symptoms are well-controlled (called 'good ON time'). About 150 adults with Parkinson's who still experience motor fluctuations despite optimize…
Phase: PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC